SLP Share Price

Open 9.28 Change Price %
High 9.30 1 Day -0.15 -1.61
Low 9.05 1 Week -0.30 -3.17
Close 9.15 1 Month 0.30 3.39
Volume 6266 1 Year -0.13 -1.40
52 Week High 11.60
52 Week Low 0.00
SLP Important Levels
Resistance 2 9.38
Resistance 1 9.29
Pivot 9.17
Support 1 9.01
Support 2 8.92
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Simulations Plus, Inc. (NASDAQ: SLP)

SLP Technical Analysis 3
As on 6th Dec 2016 SLP Share Price closed @ 9.15 and we RECOMMEND Buy for LONG-TERM with Stoploss of 8.75 & Buy for SHORT-TERM with Stoploss of 8.89 we also expect STOCK to react on Following IMPORTANT LEVELS.
SLP Target for December
1st Target up-side 10.79
2nd Target up-side 11.72
3rd Target up-side 12.66
1st Target down-side 8.11
2nd Target down-side 7.18
3rd Target down-side 6.24
SLP Other Details
Segment EQ
Market Capital 73882808.00
Sector Technology
Industry Business Software & Services
Offical website http://www.simulations-plus.com
SLP Address
SLP
42505 Tenth Street West
Lancaster, CA 93534-7059
United States
Phone: 661-723-7723
Fax: 661-723-5524
SLP Latest News
Interactive Technical Analysis Chart Simulations Plus, Inc. ( SLP NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Simulations Plus, Inc.
SLP Business Profile
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. During the fiscal year ended August 31, 2012, Words+ continued to refine its products for the disabled. The Company offers five software products for pharmaceutical research: ADMET Predictor, MedChem Designer, MedChem Studio, DDDPlus, and GastroPlus. Words+ is a wholly-owned subsidiary of the Prentke Romich Company.